Michael Gibney
Senior Editor & WriterMichael Gibney is a senior writer and editor for PharmaVoice. Before that, he covered the pharmaceutical industry as a healthcare reporter for three and a half years at S&P Global Market Intelligence and served as an editor at FiercePharma and FierceBiotech. Besides industry reporting, Michael has also covered science, wildlife and environmental issues as well as local news in Connecticut and Montana. A graduate of Bucknell University and the University of Missouri Journalism School, he is based in the Washington, D.C., area where you’ll find him hiking with two retired racing greyhounds, finding local breweries and grilling in the backyard.
9 articles by Michael Gibney
-
PBMs under fire for drug prices defend their worth
May 26, 2022 -
Pharmas can be 'more than medicine' by focusing on preventative care
May 24, 2022 -
Biotech Spotlight: Graphite Bio seeks sickle cell cure with a next-gen approach
May 17, 2022 -
With the shine of amyloid fading, tau is a rising star in Alzheimer's
May 11, 2022 -
Ultra-sensitive tests bring biomarkers into the drug development forefront
May 5, 2022 -
The 'innovation gap' haunts Big Pharma, and the race is on for the next blockbusters
April 28, 2022 -
Mouse vs. machine: Using AI to solve the animal testing model in pharma
April 26, 2022 -
A pharma mystery: Cancer-causing impurities drive joint search for answers
April 19, 2022 -
Why the war in Ukraine could accelerate the deglobalization of clinical trials
April 12, 2022